Please login to the form below

anxiety

This page shows the latest anxiety news and features for those working in and with pharma, biotech and healthcare.

Moderna looks to price COVID-19 vaccine at $50-$60 per course

If finalised, these new executive orders could force us to rethink those plans, consider job reductions and add to the economic and health anxiety already widely felt in our country,” he

Latest news

Low-dose LSD looks safe for Alzheimer’s patients, but will it work?

Earlier studies point to potential benefits for LSD in depression, anxiety, and substance abuse, and Eleusis’ hope is that low dose LSD may also have significant potential in treating Alzheimer’s,
Karuna’s shares spike on schizophrenia drug data

anxiety, that can seriously limit the clinical effectiveness of current antipsychotic drugs, most of which have been in use for decades.
Prescription drug dependence 'linked to deprivation', says PHE

This included benzodiazepines for anxiety and insomnia, z-drugs for insomnia, gapapentinoids for neuropathic pain, opioid pain medications for chronic non-cancer pain and antidepressants.
Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment

Pear Therapeutics says the study also showed improvements in anxiety symptoms (as measured by the General Anxiety Disorder 7-item (GAD-7) scale), with a treatment arm mean of 3.16
Otsuka’s Alzheimer’s agitation drug hits the mark

antipsychotic drugs – which have been linked to a higher risk of death in dementia – as well as antidepressants and anxiety medications.

More from news
Approximately 1 fully matching, plus 149 partially matching documents found.

Latest Intelligence

Health trust in a COVID-19 world – a unique opportunity for pharma

a whole has become a more valuable commodity as uncertainty and anxiety around COVID-19 and its impact has become more prevalent.
New truths and realities in these strange times

Their reality, behind their ‘locked-down’ doors, is full of concern, risk and increased anxiety that will likely impact their physical and mental health. ... Many participants in the PoTSLIVE project mentioned increased anxiety, which is a concern as
Growing up as a patient is hard to manage

Not only do many patients experience anxiety as a result of an unfamiliar care team, undefined degree of control or unexpected changes to therapy, but they can also face system-level
Integrating patient reported outcomes into clinical trials

However, the HTA acknowledges the limitations of the index, noting that “the DLQI has limited validity in some people, and may miss anxiety and depression.”.
Changing healthcare communications

Replacing anxiety with confidence, mediocrity with purpose. By David Hunt and Lou Shipley. ... But only if we replace anxiety with confidence, mediocrity with purpose, and attract the brightest, smartest and most creative minds to join our cause.

More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest appointments

Dr Niall Murphy and Pierre Schwich join Pharnext

Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
Turing names Eliseo Salinas as head of R&D

Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

The Lucid Group Wellbeing Champions embark on their MHFA training

A mentally sound organisation is good for talent and business. Statistics from Mental Health First Aid (MHFA) England point out to mental health illness (such as depression or anxiety) accounting to
Medical Device Clinical Trials 2020

Adopting virtual reality as a tool for participant retention Amazingly, virtual reality (VR) has been shown to reduce pain, anxiety and stress.
Understanding COVID-19 and varying responses across the globe

There was also investment in providing the public with four face masks per household to only be used when a member presents with symptoms in an effort to reduce public anxiety.
When community can inspire a social media movement

anxiety can take on their rosacea and mental well-being, with hints and tips to manage this.
War on drugs: the use of controlled substances in medicine

Psilocybin (aka magic mushrooms) has shown promise in treating a variety of difficult-to-treat health conditions such as depression and cancer-related anxiety.

More from PMHub
Approximately 1 fully matching, plus 33 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....